By Katy Daigle The Associated Press NEW DELHI (AP) — India effectively ended Bayer’s monopoly on a patented cancer drug last Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable. In a decision likely to upset Western pharmaceuticals, the patent office approved Natco Pharma Ltd.’s application to produce the […]